Orphan Drug Exclusivity profiles FDA-approved Orphan Drugs

Sept. 1, 2010 - PRLog -- The Orphan Drug Report profiles pharmaceutical drugs with FDA Orphan Drug Exclusivity.

The Report includes:

   * The tradename, applicant, ingredient, and Orphan exclusivity expiration dates for each Orphan Drug
   * Details on each NDA and product number, including Dosage, Strength, Approval Date, Therapeutic Equivalence (TE) code, Reference Listed Drug (RLD) indicator
   * All FDA-listed patents covering each Orphan Drug

Report highlights:

   * More than 100 pages
   * More than 80 drugs profiled

The Orphan Drug Report is available at http://www.thinkpharm.com/orphan-drug-report.html

# # #

DrugPatentWatch provides comprehensive information on drug patents and their expirations.This value-added information supports patent agents and attorneys, pharmaceutical companies, wholesalers, healthcare payers, and investors.